This is an automatically translated article.
The main ingredient of Yolipraz 40 is Telmisartan, which is indicated for the treatment of essential hypertension. So what does Yolipraz 40mg do? What precautions should be taken when using this drug? Let's find out the necessary information about the use of Yolipraz 40 through the article below.
1. What is Yolipraz 40?
Drug information:
Drug name: Yolipraz-40 Active ingredient: Telmisartan 40mg Concentration, strength: Registration number: VN-18796-15 Packing: Box of 3 blisters x 10 tablets Manufacturer: M /S Stallion Laboratories Pvt. Ltd. Distributor: Delta Medical Import Export Co., Ltd. Indications:
Essential hypertension. Dosage - Usage
Adults: 40 mg x 1 time / day, the dose can be increased to 80 mg x 1 time / day. Use as monotherapy or in combination with thiazide diuretics. No dose adjustment is required in the elderly or in renal impairment.
Mild and moderate hepatic impairment: up to 40 mg/day.
2. Side effects of Yolipraz 40
The frequency of adverse events reported with telmisartan (41.4%) was similar to that of placebo (43.9%) in the placebo-controlled trial. There was no relationship between adverse events and the dose, gender, age or race of the patients.
The adverse events listed below were cumulative from all clinical trials that included 5788 hypertensive patients treated with telmisartan.
Infections and parasites:
Urinary tract infections, upper respiratory tract infections. Mental disorders:
Anxiety, restlessness. Eye disorders: Visual disturbances. Ear and ear labyrinth disorder:
Dizziness. Gastrointestinal disorders:
Abdominal pain, diarrhea, dry mouth, indigestion, flatulence, stomach upset. Skin and subcutaneous tissue disorders:
Eczema, increased sweating. Bone, connective tissue, musculoskeletal system disorders:
Joint pain, back pain, leg cramps, leg pain, muscle pain, tendinitis-like symptoms. General Disorders and Conditions of Administration:
Chest pain, flu-like symptoms. In addition, since the introduction of telmisartan, cases of erythema, pruritus, syncope, insomnia, depression, vomiting, low blood pressure, bradycardia, tachycardia, dyspnea, leukocytosis Alkalosis, thrombocytopenia, weakness and poor performance have been reported very rarely.
As with other angiotensin II receptor antagonists, isolated cases of edema, urticaria and other associated symptoms have also been reported.
Laboratory results:
Rarely, decreased hemoglobin or increased uric acid was more common with telmisartan than with placebo. Increases in creatinine and liver enzymes were also observed with telmisartan treatment, but these biochemical changes were comparable to or lower than those observed with placebo.
3. Notes when using Yolipraz 40
Contraindications:
Hypersensitivity to the components of the drug. Pregnant women in the second and third months of pregnancy & Lactating women. Congestion. Severe liver failure. Caution:
Renal artery hypertension, kidney injury, kidney transplantation, pathology associated with RAA hyperstimulation, primary hyperaldosteronism, aortic stenosis, hypertrophic obstructive cardiomyopathy, increased blood potassium, liver failure.
Drug interactions:
Monitor digoxin levels when used together.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
